|
Oct 16
|
New data on aprocitentan to be presented at the ASN Kidney Week 2024
|
|
May 23
|
Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders
|
|
May 21
|
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
|
|
May 21
|
Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
|
|
May 21
|
Idorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable value
|